Anatoliy Shakh, MD
Vascular Surgery · Mansfield, OHNPI 1952746455
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $11,970 of the $15,630 with a category attached, or 76.6%. Medtronic accounts for 86.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $10,122 and has fallen 96.1% since, to $390 in 2025.
Across 77 payments — averaging $202.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$13K
- Boston Scientific$1K
- Silk Road Medical, Inc.$511
- W. L. Gore & Associates, Inc.$193
- Bolton Medical Inc$148
- Bard Peripheral Vascular, Inc.$97
- plus $43 from 2 others
What the payments were for
- Travel & lodging$11,97077%
- Food & beverage$3,41422%
- Education$2462%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 52 | $13,489 |
| Boston Scientific | 15 | $1,149 |
| Silk Road Medical, Inc. | 4 | $511 |
| W. L. Gore & Associates, Inc. | 2 | $193 |
| Bolton Medical Inc | 1 | $148 |
| Bard Peripheral Vascular, Inc. | 1 | $97 |
| Neuros Medical, Inc. | 1 | $26 |
| Inari Medical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IN.PACT Admiral$8,592
- ENDURANT IIS$1,522
- TurboHawk$803
- JETSTREAM SC$571
- Valiant Navion$549
- ENHANCE Transcarotid Peripheral Access Kit$453
- ENROUTE Transcarotid Stent$453
- ENROUTE Transcarotid Neuroprotection System$453
- ENROUTE .014 Guidewire$453
- Endurant$346
- TREO ABDOMINAL STENT-GRAFT SYSTEM$148
- GENERAL VASCULAR INTERVENTION$143
- CONCERTOTM$123
- Abre$108
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$105
- GENERAL ATHERECTOMY$105
How this compares
$15,630 in reported general payments places this provider in the 80th percentile of 213 vascular surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 42 | $35,798 |
| Atorvastatin Calcium | 134 | $1,296 |
| ClopidogrelClopidogrel Bisulfate | 168 | $1,286 |
| Cilostazol | 13 | $324 |
| Simvastatin | 12 | $125 |
| Pantoprazole Sodium | 11 | $77 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Mansfield
- Patrick MuckCincinnati$650K
- Sean LydenCleveland$561K
- Brian KuhnCincinnati$184K
- Vikram RaoWilloughby$137K
- Federico ParodiCleveland$78K
- Francis CaputoCleveland$75K
- Matthew RechtCincinnati$73K
- Geoffrey AnswiniCincinnati$65K
- John PigottToledo$65K
- Adam ReichardMontgomery$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.